Vaginal Microbicides
"Acceptability of a Vaginal Microbicide Among Female Sex Workers."
Published in AIDS Weekly, September 6th, 1999
According to the authors' abstract of an article published in South African Medical Journal, "Objectives: A short study was undertaken to assess the acceptability and short-term safety of a vaginal microbicide (COL-1492) and its compatibility with the preference for dry sex among sex workers at truck stops in KwaZulu-Natal. Design: A randomised double-blind placebo-controlled trial was conducted from March to July 1996. Setting: Truckstops in KwaZulu-Natal, South Africa. Participants: Twenty sex workers. The participants were assigned to either COL-1492 (which contains 52.5 mg of nonoxynol 9) or a placebo. The first month of use was followed by a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1999-09-06)
More Articles from AIDS Weekly
- Conference Coverage (IHV)
Gallo: Don't Quit Quest for Sterilizing AIDS Vaccine - Breastfeeding
Dilemma Continues For Resource-Poor Women - Conference Coverage (IHV)
Novel Chemokine Seen As Lead Molecule for AIDS Therapy - Neurodegeneration
Inflammatory Cytokine Disables Neuronal Survival Factor - Coinfection (TB/HIV)
HIV Replication in M. tb Infected Patients Studied - Gene Transfer
HIV DNA Is Transferred by an HIV Receptor-Independent Mechanism - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
